Sitapen M 50/1000 mg

Sitapen M is a medication for type 2 diabetes that combines Metformin and sitagliptin to control blood sugar levels.

• The description claims that Metformin reduces sugar absorption and liver sugar release while improving insulin use.
• The description claims that sitagliptin increases substances that make the pancreas release more insulin.
• The description claims that Sitapen M signals the liver to stop producing glucose when blood sugar is high.
• The description claims that Sitapen M does not help patients with insulin-dependent or type 1 diabetes.